{
  "symbol": "AIP",
  "company_name": "Arteris Inc",
  "ir_website": "https://ir.arteris.com/",
  "structured_data": [
    {
      "section_name": "Press Releases",
      "links": [
        {
          "title": "Arteris Selected by GigaDevice for Development in Next-Generation Automotive SoC With Enhanced FuSa Standards",
          "url": "https://ir.arteris.com/news-releases/news-release-details/arteris-selected-gigadevice-development-next-generation",
          "content": "[ Skip to main navigation ](#main-menu)\n\n[ ![logo](/sites/g/files/knoqqb68011/themes/site/nir_pid5384/dist/images/Arteris_logo_bk_org_rgb.svg) ](https://www.arteris.com/)\n\n  * [Home](/ \"Main Investor Relations Page\")\n  * [Press Releases](/news-events/news-releases)\n  * [Events and Presentations](/events-and-presentations)\n  * [Corporate Governance](/corporate-governance/governance-overview)\n    * [Governance Overview](/corporate-governance/governance-overview)\n    * [Board of Directors](https://www.arteris.com/about-arteris/leadership/#Board-of-Directors)\n    * [Management](https://www.arteris.com/management)\n    * [Committee Composition](/corporate-governance/committee-composition)\n  * [Financial Information](/financial-information/sec-filings)\n    * [SEC Filings](/financial-information/sec-filings)\n    * [Quarterly Results](/financial-information/quarterly-results)\n  * [Stock Information](/stock-information/stock-quote-chart)\n    * [Stock Quote & Chart](/stock-information/stock-quote-chart)\n    * [Analyst Coverage](/financial-information/analyst-coverage)\n  * [IR Resources](/shareholder-services/investor-faqs)\n    * [Investor FAQs](/shareholder-services/investor-faqs)\n    * [Email Alerts](/shareholder-services/email-alerts)\n    * [Contact IR](/shareholder-services/contact-ir)\n\n\n\n#  News Release Details \n\n## \n\nArteris Selected by GigaDevice for Development in Next-Generation Automotive SoC With Enhanced FuSa Standards\n\nNov 19, 2024 at 9:00 AM EST\n\n[PDF Version](/node/10006/pdf)\n\n### FlexNoC 5 interconnect IP with physical awareness improves place and route efficiency and reduces interconnect area and power consumption\n\nCAMPBELL, Calif., Nov. 19, 2024 (GLOBE NEWSWIRE) -- Arteris, Inc. (Nasdaq: AIP), a leading provider of system IP which accelerates system-on-chip (SoC) creation, today announced GigaDevice has licensed FlexNoC 5 interconnect IP to enhance product performance, reduce power consumption and shorten time to market. These solutions offer flexibility and cost-efficiency, supporting companies in developing advanced technologies.\n\nGigaDevice provides industry-proven product families. These products offer high performance and reliability for applications requiring automotive-grade solutions. Committed to meeting the stringent standards of the automotive industry, the company focuses on innovation and quality. Its products incorporate functional safety to address the demands of modern automotive technology.\n\n“We chose Arteris because of its proven track record in interconnect technology and experienced support team,” said Sherry Jia, Senior Director of MCU Department, GigaDevice. “FlexNoC 5 is especially valuable when managing the complexities of functional safety standards.”\n\n“We are thrilled to bring our advanced interconnect IP to GigaDevice’s automotive products,” said K. Charles Janac, president and CEO of Arteris. “We are dedicated to supporting our customer’s mission of creating cutting-edge automotive solutions that meet the highest standards of safety and performance.”\n\nArteris' FlexNoC 5 interconnect IP delivers high performance, flexibility and scalability. It integrates hardware reliability and functional safety features, ensuring compliance with industry standards. The NoC’s physical awareness allows SoC architects to anticipate design challenges early on, significantly reducing iteration cycles.\n\n**About Arteris**\n\nArteris is a leading provider of system IP for the acceleration of system-on-chip (SoC) development across today's electronic systems. Arteris network-on-chip (NoC) interconnect IP and SoC integration automation technology enable higher product performance with lower power consumption and faster time to market, delivering better SoC economics so its customers can focus on dreaming up what comes next. Learn more at [arteris.com](https://www.globenewswire.com/Tracker?data=Tjztc0dJN1UkEHLzYpYs6O1WB9lEQy1X3fsnKOMbs8xDBWcjE2xVYYh8YNNBhXwjoOkXujH0BtH9UToS3zXw9Q==).\n\n**About GigaDevice**\n\nGigaDevice Semiconductor Inc. (SSE Stock Code 603986) is a leading global fabless supplier. The company was founded in April 2005 with branch offices in many countries and regions worldwide, providing local support at customers' fingertips. Committed to building a complete ecosystem with major product lines – Flash memory, MCU, sensor, and power as the core driving force, GigaDevice can provide a wide range of solutions and services in the fields of industrial, automotive, computing, consumer electronics, IoT, mobile, networking, and communications. GigaDevice management system has achieved ISO 9001:2015 and ISO 14001:2015 certifications. Constantly looking to expand the technology offering to customers, GigaDevice has also formed multiple strategic alliances with leading foundries, assembly, and test plants to streamline supply chain management. For more details, please visit: [www.gigadevice.com](https://www.globenewswire.com/Tracker?data=z1jqSRpd-wUBbXP5e2c4NmxvaDdM5_aflKUq6MRUWw7dwsT919Q1SuqXBLnQRl7mHJybQ9_ELNOPGlEEPEuHQAsg8zPz1dXUX9vyj0btbok=).\n\n_© 2004-2024 Arteris, Inc. All rights reserved worldwide. Arteris, Arteris IP, the Arteris IP logo, and the other Arteris marks found at_[ __https://www.arteris.com/trademarks__](https://www.globenewswire.com/Tracker?data=v7v2dB4-aqldzWKZQlbGQsBFjVHwdTrW4RtRqc8t-5XqiSs4QX8Ldxxw22KoDhZgdaN7jfnGZ8As085VEjd9tkk0EFa9UDQJQ7HxXf229Eg4PwNnCXVsRJd8LnNZ15VR) _are_ _trademarks or registered trademarks of Arteris, Inc. or its subsidiaries. All other trademarks are the property of their respective owners._\n\nMedia Contact:Gina JacobsArteris+1 408 560 3044[newsroom@arteris.com](https://www.globenewswire.com/Tracker?data=qHER8KyNstVHWYnD53ykiKAlAqLQ3gFhTGrwOQnmxifkp6mfFzfMYWC1bG0-SFRQjRaXtyP1mVHzO8PDhkJeaSrQa_GUCSLH9h0sSCxyWwo=)\n\nThis press release was published by a CLEAR® Verified individual.\n\n![](https://ml.globenewswire.com/media/YzlkYjc1ZjQtMWIyZC00MzQxLTgwZWEtZDFlNWQ1NDZlZDNjLTEyMjI2Mzc=/tiny/Arteris-Inc-.png)\n\nRequest Email Alerts\n\n### Contact\n\n#### Americas\n\n**Arteris Headquarters** 900 E. Hamilton Avenue, Suite 300Campbell, CA 95008 USA+1 408 470 7300Contact: info@arteris.com\n\n**Arteris Austin** 9601 Amberglen Blvd, Suite 117Austin, TX 78729 USA\n\n#### Europe\n\n**Arteris Montigny** 2 Rue George Stephenson78180 Montigny le Bretonneux, France+33 1 61 37 38 40\n\n**Arteris Nice** 240 Rue Evariste Galois06410 Biot, France\n\n**Arteris Paris** 251 Rue du Faubourg Saint-Martin75010 Paris, France+33 1 40 21 35 50\n\n#### Asia\n\n**Arteris Nanjing** Room 2708, Yunfeng MansionNo. 8 Zhongshan North RoadNanjing, China, 210038安通思半导体技术（南京）有限公司南京市鼓楼区中山北路8号云峰大厦2708室邮编 210008\n\n**Arteris Seoul** U-Space 2B, #1001,670, Daewangpangyo-ro Bundang-gu, Seongnam-si, Gyeonggi-do, Seoul 13494 Korea+82 (10) 4704 9526\n\n**Arteris Tokyo** #402, 2-10-15 Shibuya, Shibuya-kuTokyo, Japan 150-0002+81 3 4405 0399\n\n#### Support\n\nNeed help? Visit the [helpdesk](https://arterisip.atlassian.net/servicedesk)Semiconductor IP: help@arteris.comIP Deployment: mds_service_desk@arteris.com\n\n### Connect With Us\n\n[](https://twitter.com/arteris_noc) [](https://www.linkedin.com/company/30628)\n\n### Legal\n\n[Terms of Use](https://www.arteris.com/terms-of-use) [Privacy Policy](https://www.arteris.com/privacy) [Trademarks & Copyrights](https://www.arteris.com/legal/trademarks) [Trademark Usage Guidelines](https://www.arteris.com/en/trademarks-guidelines) [Manage My Privacy](https://privacyportal.onetrust.com/webform/10c5e60f-f275-434d-944b-42efe82f6bf2/ef35fd8d-582f-418e-840e-1f0f29f2f3e8) [Do Not Sell/Share My Information](https://privacyportal.onetrust.com/webform/10c5e60f-f275-434d-944b-42efe82f6bf2/ef35fd8d-582f-418e-840e-1f0f29f2f3e8)\n\nCopyright © 2004-2024 Arteris, Inc. and its affiliates. All rights reserved. Modification or reproduction in any form whatsoever, without prior written consent of Arteris, Inc. or its designated affiliate(s), is strictly forbidden. \n\n[](# \"Back to Top\")\n"
        },
        {
          "title": "Arteris and MIPS Partner on High-Performance RISC-V SoCs for Automotive, Datacenter and Edge AI",
          "url": "https://ir.arteris.com/news-releases/news-release-details/arteris-and-mips-partner-high-performance-risc-v-socs-automotive",
          "content": "[ Skip to main navigation ](#main-menu)\n\n[ ![logo](/sites/g/files/knoqqb68011/themes/site/nir_pid5384/dist/images/Arteris_logo_bk_org_rgb.svg) ](https://www.arteris.com/)\n\n  * [Home](/ \"Main Investor Relations Page\")\n  * [Press Releases](/news-events/news-releases)\n  * [Events and Presentations](/events-and-presentations)\n  * [Corporate Governance](/corporate-governance/governance-overview)\n    * [Governance Overview](/corporate-governance/governance-overview)\n    * [Board of Directors](https://www.arteris.com/about-arteris/leadership/#Board-of-Directors)\n    * [Management](https://www.arteris.com/management)\n    * [Committee Composition](/corporate-governance/committee-composition)\n  * [Financial Information](/financial-information/sec-filings)\n    * [SEC Filings](/financial-information/sec-filings)\n    * [Quarterly Results](/financial-information/quarterly-results)\n  * [Stock Information](/stock-information/stock-quote-chart)\n    * [Stock Quote & Chart](/stock-information/stock-quote-chart)\n    * [Analyst Coverage](/financial-information/analyst-coverage)\n  * [IR Resources](/shareholder-services/investor-faqs)\n    * [Investor FAQs](/shareholder-services/investor-faqs)\n    * [Email Alerts](/shareholder-services/email-alerts)\n    * [Contact IR](/shareholder-services/contact-ir)\n\n\n\n#  News Release Details \n\n## \n\nArteris and MIPS Partner on High-Performance RISC-V SoCs for Automotive, Datacenter and Edge AI\n\nNov 12, 2024 at 9:00 AM EST\n\n[PDF Version](/node/9986/pdf)\n\n### Pre-verified reference platform supports the acceleration of RISC-V-based SoC designs with mutual customers\n\nCAMPBELL, Calif., Nov. 12, 2024 (GLOBE NEWSWIRE) -- November 12, 2024 – Arteris, Inc. (Nasdaq: AIP), a leading provider of system IP which accelerates system-on-chip (SoC) creation and MIPS, a leading provider of efficient and configurable compute core IP, today announced a partnership to provide a pre-verified reference platform to support mutual customers. The creation of this pre-verified reference platform is designed to shorten development cycles and reduce risk for RISC-V-based chip designs for automotive, enterprise computing and edge AI applications.\n\nMIPS develops high-performance RISC-V CPU IP for AI, automotive and general-purpose computing. By pre-integrating Arteris network-on-chip IP, including Ncore cache coherent NoC IP and FlexNoC IP with the MIPS P8700 processor core clusters, the two IP providers demonstrate the interoperability and performance of the joint solution. Customers can confidently leverage the silicon-proven solution demonstrated by a pre-verified reference platform supported by both Arteris and MIPS.\n\nArteris network-on-chip IP technology provides on-die or on-chip connectivity, supporting both homogeneous and heterogeneous architectures, and can simultaneously handle AMBA ACE and CHI protocols. This unique flexibility and configurability facilitate quick development and optimized RISC-V-based SoCs.\n\n“We are pleased to work with Arteris, whose Ncore and FlexNoC IPs have been deployed by our customers. This partnership allows us to deliver a pre-verified solution that mitigates risk and accelerates our customers' design time,” said Drew Barbier, VP of product at MIPS. “Many of our shared customers have successfully deployed our technologies, and this partnership enables us to better meet the demands of advanced automotive and general-purpose applications.”\n\n“We are excited to support MIPS in the development of their next-generation RISC-V processor cores and support our mutual customers with this pre-verified solution,” said Michal Siwinski, CMO of Arteris. “This partnership underscores our commitment to support the broader ecosystem by delivering RISC-V ready NoC interconnects that not only enhance performance and reduce SoC power, but also improve scalability for future electronic innovations.”\n\nFor additional information about MIPS, please visit [mips.com](https://www.globenewswire.com/Tracker?data=GlhAP__rAx8YF4RCqKbftddl98SCTuFInScUv5XAOxTx3TVIZB3iWsAgPUY6YWuGNAm_H7p6yGO-f8BzjkIq2Q==). For additional information about Arteris’ RISC-V ecosystem support, please visit [www.arteris.com/solutions/risc-v](https://www.globenewswire.com/Tracker?data=uFUtKNAIMdO6Ekhrbo5sgbZ8qKdDCXTscQHUA5nxr6fRKtictFJ9f2Af0qtCaCrGJF-vRrjcdtEXH7VYDHfnj_lgdb3dApixRH6YOyoFL5DpInXibtKj1IfwZytzN7QB).\n\n**About Arteris**\n\nArteris is a leading provider of system IP for the acceleration of system-on-chip (SoC) development across today’s electronic systems. Arteris network-on-chip (NoC) interconnect IP and SoC integration automation technology enable higher product performance with lower power consumption and faster time to market, delivering better SoC economics so its customers can focus on dreaming up what comes next. Learn more at [arteris.com](https://www.globenewswire.com/Tracker?data=EtIJjUaL8lc0y_w5vMlTqI68WL5FlU3j-u3CaAFGET1nOpSUyJRq8JeclBKbK8VcxBkazP2gCNyotswCC9FBpQ==).\n\n**About MIPS**\n\nMIPS is accelerating compute density in the automotive, cloud and embedded markets. Giving customers the freedom to build unique products for specific workloads, MIPS’ industry-leading cores are configurable, efficient and easy to implement. Its multi-threading methodology delivers advanced scalability and the ability to efficiently move and process data faster. The company’s compute DNA spans three decades with billions of MIPS-based chips shipped to date. For more information, visit MIPS.com.\n\n_© 2004-2024 Arteris, Inc. All rights reserved worldwide. Arteris, Arteris IP, the Arteris IP logo, and the other Arteris marks found at_[ _https://www.arteris.com/trademarks_](https://www.globenewswire.com/Tracker?data=4Q6m5Wt73tPfA7sqJFCFeTssDgwUMSbv8kv9-mcgUA_v-bjMq_hh0IhyrN650Fd0DpaPMFMdGFzcwKD4Rk7uQBoYi4Dv65XpCxkQCc6OIL1WvNwEjEZEi_khWdK9l2rw) _are trademarks or registered trademarks of Arteris, Inc. or its subsidiaries. All other trademarks are the property of their respective owners._\n\nThis press release was published by a CLEAR® Verified individual.\n\n![](https://ml.globenewswire.com/media/MDEzYTcwYTUtNzYyNC00YzU3LTk2NTItMWVkNjc5YjIzZmZmLTEyMjI2Mzc=/tiny/Arteris-Inc-.png)\n\nMedia Contact: Gina Jacobs Arteris +1 408 560 3044 newsroom@arteris.com\n\nRequest Email Alerts\n\n### Contact\n\n#### Americas\n\n**Arteris Headquarters** 900 E. Hamilton Avenue, Suite 300Campbell, CA 95008 USA+1 408 470 7300Contact: info@arteris.com\n\n**Arteris Austin** 9601 Amberglen Blvd, Suite 117Austin, TX 78729 USA\n\n#### Europe\n\n**Arteris Montigny** 2 Rue George Stephenson78180 Montigny le Bretonneux, France+33 1 61 37 38 40\n\n**Arteris Nice** 240 Rue Evariste Galois06410 Biot, France\n\n**Arteris Paris** 251 Rue du Faubourg Saint-Martin75010 Paris, France+33 1 40 21 35 50\n\n#### Asia\n\n**Arteris Nanjing** Room 2708, Yunfeng MansionNo. 8 Zhongshan North RoadNanjing, China, 210038安通思半导体技术（南京）有限公司南京市鼓楼区中山北路8号云峰大厦2708室邮编 210008\n\n**Arteris Seoul** U-Space 2B, #1001,670, Daewangpangyo-ro Bundang-gu, Seongnam-si, Gyeonggi-do, Seoul 13494 Korea+82 (10) 4704 9526\n\n**Arteris Tokyo** #402, 2-10-15 Shibuya, Shibuya-kuTokyo, Japan 150-0002+81 3 4405 0399\n\n#### Support\n\nNeed help? Visit the [helpdesk](https://arterisip.atlassian.net/servicedesk)Semiconductor IP: help@arteris.comIP Deployment: mds_service_desk@arteris.com\n\n### Connect With Us\n\n[](https://twitter.com/arteris_noc) [](https://www.linkedin.com/company/30628)\n\n### Legal\n\n[Terms of Use](https://www.arteris.com/terms-of-use) [Privacy Policy](https://www.arteris.com/privacy) [Trademarks & Copyrights](https://www.arteris.com/legal/trademarks) [Trademark Usage Guidelines](https://www.arteris.com/en/trademarks-guidelines) [Manage My Privacy](https://privacyportal.onetrust.com/webform/10c5e60f-f275-434d-944b-42efe82f6bf2/ef35fd8d-582f-418e-840e-1f0f29f2f3e8) [Do Not Sell/Share My Information](https://privacyportal.onetrust.com/webform/10c5e60f-f275-434d-944b-42efe82f6bf2/ef35fd8d-582f-418e-840e-1f0f29f2f3e8)\n\nCopyright © 2004-2024 Arteris, Inc. and its affiliates. All rights reserved. Modification or reproduction in any form whatsoever, without prior written consent of Arteris, Inc. or its designated affiliate(s), is strictly forbidden. \n\n[](# \"Back to Top\")\n"
        }
      ]
    },
    {
      "section_name": "Events",
      "links": [
        {
          "title": "Northland’s Growth Virtual Conference 2024",
          "url": "https://ir.arteris.com/events/event-details/northlands-growth-conference-2024-0",
          "content": "[ Skip to main navigation ](#main-menu)\n\n[ ![logo](/sites/g/files/knoqqb68011/themes/site/nir_pid5384/dist/images/Arteris_logo_bk_org_rgb.svg) ](https://www.arteris.com/)\n\n  * [Home](/ \"Main Investor Relations Page\")\n  * [Press Releases](/news-events/news-releases)\n  * [Events and Presentations](/events-and-presentations)\n  * [Corporate Governance](/corporate-governance/governance-overview)\n    * [Governance Overview](/corporate-governance/governance-overview)\n    * [Board of Directors](https://www.arteris.com/about-arteris/leadership/#Board-of-Directors)\n    * [Management](https://www.arteris.com/management)\n    * [Committee Composition](/corporate-governance/committee-composition)\n  * [Financial Information](/financial-information/sec-filings)\n    * [SEC Filings](/financial-information/sec-filings)\n    * [Quarterly Results](/financial-information/quarterly-results)\n  * [Stock Information](/stock-information/stock-quote-chart)\n    * [Stock Quote & Chart](/stock-information/stock-quote-chart)\n    * [Analyst Coverage](/financial-information/analyst-coverage)\n  * [IR Resources](/shareholder-services/investor-faqs)\n    * [Investor FAQs](/shareholder-services/investor-faqs)\n    * [Email Alerts](/shareholder-services/email-alerts)\n    * [Contact IR](/shareholder-services/contact-ir)\n\n\n\n#  Event Details \n\n## Northland’s Growth Virtual Conference 2024\n\n###  Thursday Dec 12, 2024 \n\n[Add to Outlook](/node/9826/ics)\n\n[Add to Google Calendar](https://www.google.com/calendar/render?action=TEMPLATE&text=Arteris, Inc. - Northland’s Growth Virtual Conference 2024&dates=20241212T220000Z/20241212T220000Z&details=Event Details: https://ir.arteris.com/events/event-details/northlands-growth-conference-2024-0&location=&trp=false&sprop=&sprop=name:)\n\nRequest Email Alerts\n\n### Contact\n\n#### Americas\n\n**Arteris Headquarters** 900 E. Hamilton Avenue, Suite 300Campbell, CA 95008 USA+1 408 470 7300Contact: info@arteris.com\n\n**Arteris Austin** 9601 Amberglen Blvd, Suite 117Austin, TX 78729 USA\n\n#### Europe\n\n**Arteris Montigny** 2 Rue George Stephenson78180 Montigny le Bretonneux, France+33 1 61 37 38 40\n\n**Arteris Nice** 240 Rue Evariste Galois06410 Biot, France\n\n**Arteris Paris** 251 Rue du Faubourg Saint-Martin75010 Paris, France+33 1 40 21 35 50\n\n#### Asia\n\n**Arteris Nanjing** Room 2708, Yunfeng MansionNo. 8 Zhongshan North RoadNanjing, China, 210038安通思半导体技术（南京）有限公司南京市鼓楼区中山北路8号云峰大厦2708室邮编 210008\n\n**Arteris Seoul** U-Space 2B, #1001,670, Daewangpangyo-ro Bundang-gu, Seongnam-si, Gyeonggi-do, Seoul 13494 Korea+82 (10) 4704 9526\n\n**Arteris Tokyo** #402, 2-10-15 Shibuya, Shibuya-kuTokyo, Japan 150-0002+81 3 4405 0399\n\n#### Support\n\nNeed help? Visit the [helpdesk](https://arterisip.atlassian.net/servicedesk)Semiconductor IP: help@arteris.comIP Deployment: mds_service_desk@arteris.com\n\n### Connect With Us\n\n[](https://twitter.com/arteris_noc) [](https://www.linkedin.com/company/30628)\n\n### Legal\n\n[Terms of Use](https://www.arteris.com/terms-of-use) [Privacy Policy](https://www.arteris.com/privacy) [Trademarks & Copyrights](https://www.arteris.com/legal/trademarks) [Trademark Usage Guidelines](https://www.arteris.com/en/trademarks-guidelines) [Manage My Privacy](https://privacyportal.onetrust.com/webform/10c5e60f-f275-434d-944b-42efe82f6bf2/ef35fd8d-582f-418e-840e-1f0f29f2f3e8) [Do Not Sell/Share My Information](https://privacyportal.onetrust.com/webform/10c5e60f-f275-434d-944b-42efe82f6bf2/ef35fd8d-582f-418e-840e-1f0f29f2f3e8)\n\nCopyright © 2004-2024 Arteris, Inc. and its affiliates. All rights reserved. Modification or reproduction in any form whatsoever, without prior written consent of Arteris, Inc. or its designated affiliate(s), is strictly forbidden. \n\n[](# \"Back to Top\")\n\nThis website stores cookies on your computer. These cookies are used to collect information about how you interact with our website and allow us to remember you. We use this information in order to improve and customize your browsing experience and for analytics and metrics about our visitors both on this website and other media. To find out more about the cookies we use, see our[Privacy Policy](https://www.arteris.com/privacy/)\n\nAccept All Cookies\n\nManage Cookies\n\n![Arteris logo](https://cdn.cookielaw.org/logos/10c5e60f-f275-434d-944b-42efe82f6bf2/ec3fa55b-bcc3-4e07-a809-7d718a6bcde9/238882af-4102-4fd3-8930-4af49e9ab198/arteris-logo.png)\n\n## Privacy Preference Center\n\nWhen you visit any website, it may store or retrieve information on your browser, mostly in the form of cookies. This information might be about you, your preferences or your device and is mostly used to make the site work as you expect it to. The information does not usually directly identify you, but it can give you a more personalized web experience. Because we respect your right to privacy, you can choose not to allow some types of cookies. Click on the different category headings to find out more and change our default settings. However, blocking some types of cookies may impact your experience of the site and the services we are able to offer. [Privacy Policy](https://www.arteris.com/privacy/)\n\nAllow All\n\n###  Manage Consent Preferences\n\n#### Strictly Necessary Cookies\n\nAlways Active\n\nThese cookies are necessary for the website to function and cannot be switched off in our systems. They are usually only set in response to actions made by you which amount to a request for services, such as setting your privacy preferences, logging in or filling in forms. You can set your browser to block or alert you about these cookies, but some parts of the site will not then work. These cookies do not store any personally identifiable information.\n\n#### Functional Cookies\n\nFunctional Cookies\n\nThese cookies enable the website to provide enhanced functionality and personalization. They may be set by us or by third party providers whose services we have added to our pages. If you do not allow these cookies then some or all of these services may not function properly.\n\n#### Performance Cookies\n\nPerformance Cookies\n\nThese cookies allow us to count visits and traffic sources so we can measure and improve the performance of our site. They help us to know which pages are the most and least popular and see how visitors move around the site. All information these cookies collect is aggregated and therefore anonymous. If you do not allow these cookies we will not know when you have visited our site, and will not be able to monitor its performance.\n\n#### Targeting Cookies\n\nTargeting Cookies\n\nThese cookies may be set through our site by our advertising partners. They may be used by those companies to build a profile of your interests and show you relevant adverts on other sites. They do not store directly personal information, but are based on uniquely identifying your browser and internet device. If you do not allow these cookies, you will experience less targeted advertising.\n\nBack Button\n\n### Cookie List\n\nSearch Icon\n\nFilter Icon\n\nClear\n\ncheckbox label label\n\nApply Cancel\n\nConsent Leg.Interest\n\ncheckbox label label\n\ncheckbox label label\n\ncheckbox label label\n\nOnly Essential Cookies Confirm My Choices\n\n[![Powered by Onetrust](https://cdn.cookielaw.org/logos/static/powered_by_logo.svg)](https://www.onetrust.com/products/cookie-consent/)\n"
        },
        {
          "title": "27th Annual Needham Growth Virtual Conference",
          "url": "https://ir.arteris.com/events/event-details/27th-annual-needham-growth-virtual-conference",
          "content": "[ Skip to main navigation ](#main-menu)\n\n[ ![logo](/sites/g/files/knoqqb68011/themes/site/nir_pid5384/dist/images/Arteris_logo_bk_org_rgb.svg) ](https://www.arteris.com/)\n\n  * [Home](/ \"Main Investor Relations Page\")\n  * [Press Releases](/news-events/news-releases)\n  * [Events and Presentations](/events-and-presentations)\n  * [Corporate Governance](/corporate-governance/governance-overview)\n    * [Governance Overview](/corporate-governance/governance-overview)\n    * [Board of Directors](https://www.arteris.com/about-arteris/leadership/#Board-of-Directors)\n    * [Management](https://www.arteris.com/management)\n    * [Committee Composition](/corporate-governance/committee-composition)\n  * [Financial Information](/financial-information/sec-filings)\n    * [SEC Filings](/financial-information/sec-filings)\n    * [Quarterly Results](/financial-information/quarterly-results)\n  * [Stock Information](/stock-information/stock-quote-chart)\n    * [Stock Quote & Chart](/stock-information/stock-quote-chart)\n    * [Analyst Coverage](/financial-information/analyst-coverage)\n  * [IR Resources](/shareholder-services/investor-faqs)\n    * [Investor FAQs](/shareholder-services/investor-faqs)\n    * [Email Alerts](/shareholder-services/email-alerts)\n    * [Contact IR](/shareholder-services/contact-ir)\n\n\n\n#  Event Details \n\n## 27th Annual Needham Growth Virtual Conference\n\n###  Thursday Jan 16, 2025 at 4:30 PM EST \n\n[Add to Outlook](/node/10016/ics)\n\n[Add to Google Calendar](https://www.google.com/calendar/render?action=TEMPLATE&text=Arteris, Inc. - 27th Annual Needham Growth Virtual Conference&dates=20250116T213000Z/20250116T213000Z&details=Event Details: https://ir.arteris.com/events/event-details/27th-annual-needham-growth-virtual-conference%0A%0AWebcast: https://wsw.com/webcast/needham143/aip/2047364&location=&trp=false&sprop=&sprop=name:)\n\n[Click here for webcast](https://wsw.com/webcast/needham143/aip/2047364)\n\nRequest Email Alerts\n\n### Contact\n\n#### Americas\n\n**Arteris Headquarters** 900 E. Hamilton Avenue, Suite 300Campbell, CA 95008 USA+1 408 470 7300Contact: info@arteris.com\n\n**Arteris Austin** 9601 Amberglen Blvd, Suite 117Austin, TX 78729 USA\n\n#### Europe\n\n**Arteris Montigny** 2 Rue George Stephenson78180 Montigny le Bretonneux, France+33 1 61 37 38 40\n\n**Arteris Nice** 240 Rue Evariste Galois06410 Biot, France\n\n**Arteris Paris** 251 Rue du Faubourg Saint-Martin75010 Paris, France+33 1 40 21 35 50\n\n#### Asia\n\n**Arteris Nanjing** Room 2708, Yunfeng MansionNo. 8 Zhongshan North RoadNanjing, China, 210038安通思半导体技术（南京）有限公司南京市鼓楼区中山北路8号云峰大厦2708室邮编 210008\n\n**Arteris Seoul** U-Space 2B, #1001,670, Daewangpangyo-ro Bundang-gu, Seongnam-si, Gyeonggi-do, Seoul 13494 Korea+82 (10) 4704 9526\n\n**Arteris Tokyo** #402, 2-10-15 Shibuya, Shibuya-kuTokyo, Japan 150-0002+81 3 4405 0399\n\n#### Support\n\nNeed help? Visit the [helpdesk](https://arterisip.atlassian.net/servicedesk)Semiconductor IP: help@arteris.comIP Deployment: mds_service_desk@arteris.com\n\n### Connect With Us\n\n[](https://twitter.com/arteris_noc) [](https://www.linkedin.com/company/30628)\n\n### Legal\n\n[Terms of Use](https://www.arteris.com/terms-of-use) [Privacy Policy](https://www.arteris.com/privacy) [Trademarks & Copyrights](https://www.arteris.com/legal/trademarks) [Trademark Usage Guidelines](https://www.arteris.com/en/trademarks-guidelines) [Manage My Privacy](https://privacyportal.onetrust.com/webform/10c5e60f-f275-434d-944b-42efe82f6bf2/ef35fd8d-582f-418e-840e-1f0f29f2f3e8) [Do Not Sell/Share My Information](https://privacyportal.onetrust.com/webform/10c5e60f-f275-434d-944b-42efe82f6bf2/ef35fd8d-582f-418e-840e-1f0f29f2f3e8)\n\nCopyright © 2004-2024 Arteris, Inc. and its affiliates. All rights reserved. Modification or reproduction in any form whatsoever, without prior written consent of Arteris, Inc. or its designated affiliate(s), is strictly forbidden. \n\n[](# \"Back to Top\")\n"
        }
      ]
    },
    {
      "section_name": "Financial Information",
      "links": [
        {
          "title": "SEC Filings",
          "url": "https://ir.arteris.com/financial-information/sec-filings",
          "content": "[ Skip to main navigation ](#main-menu)\n\n[ ![logo](/sites/g/files/knoqqb68011/themes/site/nir_pid5384/dist/images/Arteris_logo_bk_org_rgb.svg) ](https://www.arteris.com/)\n\n  * [Home](/ \"Main Investor Relations Page\")\n  * [Press Releases](/news-events/news-releases)\n  * [Events and Presentations](/events-and-presentations)\n  * [Corporate Governance](/corporate-governance/governance-overview)\n    * [Governance Overview](/corporate-governance/governance-overview)\n    * [Board of Directors](https://www.arteris.com/about-arteris/leadership/#Board-of-Directors)\n    * [Management](https://www.arteris.com/management)\n    * [Committee Composition](/corporate-governance/committee-composition)\n  * [Financial Information](/financial-information/sec-filings)\n    * [SEC Filings](/financial-information/sec-filings)\n    * [Quarterly Results](/financial-information/quarterly-results)\n  * [Stock Information](/stock-information/stock-quote-chart)\n    * [Stock Quote & Chart](/stock-information/stock-quote-chart)\n    * [Analyst Coverage](/financial-information/analyst-coverage)\n  * [IR Resources](/shareholder-services/investor-faqs)\n    * [Investor FAQs](/shareholder-services/investor-faqs)\n    * [Email Alerts](/shareholder-services/email-alerts)\n    * [Contact IR](/shareholder-services/contact-ir)\n\n\n\n#  SEC Filings \n\nGroup 3,4,5Annual FilingsCurrent ReportsMergers & AcquisitionsOtherProxy FilingsQuarterly FilingsRegistration Statements\n\nFiling year - Any -202420232022202120202019201820172016\n\n- Any -\n\nItems per page 102550\n\n10\n\n[Filing date ](?items_per_page=10&order=field_nir_sec_date_filed&sort=asc \"sort by Filing date\") | [Description](?items_per_page=10&order=field_nir_sec_description&sort=asc \"sort by Description\") | [Form](?items_per_page=10&order=field_nir_sec_form&sort=asc \"sort by Form\") | Filing Group | View  \n---|---|---|---|---  \nNov 15, 2024 | Statement of changes in beneficial ownership of securities | [4](/sec-filings/sec-filing/4/0001562180-24-007732) |  3,4,5 |  [0001562180-24-007732.pdf](/static-files/06a99f53-5525-4174-ad32-3e338798b83d) [0001562180-24-007732.rtf](/static-files/2619a4c8-0c50-422c-a218-4d2ed884b707) [0001562180-24-007732.xls](/static-files/74ee69eb-91f1-4076-8722-f14e8c8c061e) [View HTML](/node/9996/html)  \nNov 13, 2024 | An amendment to the SC 13G filing | [SC 13G/A](/sec-filings/sec-filing/sc-13ga/0001193125-24-257275) |  Other |  [0001193125-24-257275.pdf](/static-files/2be6126e-bea2-4b85-8ae9-919b19b2f6db) [0001193125-24-257275.rtf](/static-files/67b803eb-0d2d-48dd-b40a-4460c3622b12) [0001193125-24-257275.xls](/static-files/aadc2578-f4ba-4cf1-b18b-87c9994fb4e0) [View HTML](/node/9991/html)  \nNov 08, 2024 | Statement of changes in beneficial ownership of securities | [4](/sec-filings/sec-filing/4/0001562180-24-007613) |  3,4,5 |  [0001562180-24-007613.pdf](/static-files/6ce314b4-49e4-44b1-8aff-943b2be237d0) [0001562180-24-007613.rtf](/static-files/0e4ad3cd-7fed-4e5d-b66d-9bed633011a9) [0001562180-24-007613.xls](/static-files/4e5c1bff-18cc-4454-9c29-03c84dbe9b21) [View HTML](/node/9976/html)  \nNov 06, 2024 | Filed by \"insiders\" prior intended sale of restricted stock. Non-EDGAR filing | [144](/sec-filings/sec-filing/144/0001950047-24-008164) |  Other |  [0001950047-24-008164.pdf](/static-files/7c7fb1ae-6de0-4062-9b52-ce3df45bd5f8) [0001950047-24-008164.rtf](/static-files/db06a2ad-4c5c-4a7a-9102-c646efda03b8) [0001950047-24-008164.xls](/static-files/8cd30254-7830-4765-9d94-ed31e5bd68b9) [View HTML](/node/9971/html)  \nNov 05, 2024 | Report of unscheduled material events or corporate event | [8-K](/sec-filings/sec-filing/8-k/0001667011-24-000035) |  Current Reports |  [0001667011-24-000035.pdf](/static-files/04574161-5e59-4168-8b24-181d77abfbba) [0001667011-24-000035.rtf](/static-files/cf651741-dcc9-48e9-b5a2-7dd87c73bee7) [0001667011-24-000035.xls](/static-files/6ef9522d-824b-4feb-abbc-f9d1ab645eae) [EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA](/sec-filings/sec-filing/8-k/0001667011-24-000035) [View HTML](/node/9961/html)  \nNov 05, 2024 | Quarterly report which provides a continuing view of a company's financial position | [10-Q](/sec-filings/sec-filing/10-q/0001667011-24-000036) |  Quarterly Filings |  [0001667011-24-000036.pdf](/static-files/787ee384-1fbf-4c97-825c-064387333efc) [0001667011-24-000036.rtf](/static-files/3886ef19-2859-4b1a-91a6-9cbf77d68065) [0001667011-24-000036.xls](/static-files/9aab2162-a6f5-4879-ad26-e24a87b190ba) [EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA](/sec-filings/sec-filing/10-q/0001667011-24-000036) [View HTML](/node/9966/html)  \nNov 04, 2024 | Statement of changes in beneficial ownership of securities | [4](/sec-filings/sec-filing/4/0001562180-24-007521) |  3,4,5 |  [0001562180-24-007521.pdf](/static-files/0daad3b4-16db-4367-9e7d-99a47a364743) [0001562180-24-007521.rtf](/static-files/0954df3f-8dd4-4e7d-8ee0-ffbbf9076844) [0001562180-24-007521.xls](/static-files/50f1484d-0306-4e4a-8817-d6125a9510c7) [View HTML](/node/9926/html)  \nNov 01, 2024 | Filed by \"insiders\" prior intended sale of restricted stock. Non-EDGAR filing | [144](/sec-filings/sec-filing/144/0001950047-24-008042) |  Other |  [0001950047-24-008042.pdf](/static-files/5cc9b018-d399-4acd-842e-099d1aa4a2dc) [0001950047-24-008042.rtf](/static-files/988b83bf-3a04-4569-8666-7cf858c9eb36) [View HTML](/node/9921/html)  \nOct 08, 2024 | Statement of changes in beneficial ownership of securities | [4](/sec-filings/sec-filing/4/0001562180-24-007271) |  3,4,5 |  [0001562180-24-007271.pdf](/static-files/87ae9070-e075-4485-b913-8c7548f6fb8f) [0001562180-24-007271.rtf](/static-files/9e575d59-b3ac-464c-b02b-369c5703bdfa) [0001562180-24-007271.xls](/static-files/4fea0535-7d0c-4deb-b9e7-df3c45b59d1d) [View HTML](/node/9851/html)  \nOct 08, 2024 | Statement of changes in beneficial ownership of securities | [4](/sec-filings/sec-filing/4/0001562180-24-007269) |  3,4,5 |  [0001562180-24-007269.pdf](/static-files/812c711f-aa6a-4d42-8260-1e662f55940c) [0001562180-24-007269.rtf](/static-files/a8cb8fae-268c-4cd4-95b5-838f69b46b1b) [0001562180-24-007269.xls](/static-files/d31b52b8-e26c-4b25-99fd-527c64d4ee82) [View HTML](/node/9856/html)  \n  \nDisplaying 1 - 10 of 355 results\n\nData provided by [Kaleidoscope](https://www.kscope.io).\n\nRequest Email Alerts\n\n### Contact\n\n#### Americas\n\n**Arteris Headquarters** 900 E. Hamilton Avenue, Suite 300Campbell, CA 95008 USA+1 408 470 7300Contact: info@arteris.com\n\n**Arteris Austin** 9601 Amberglen Blvd, Suite 117Austin, TX 78729 USA\n\n#### Europe\n\n**Arteris Montigny** 2 Rue George Stephenson78180 Montigny le Bretonneux, France+33 1 61 37 38 40\n\n**Arteris Nice** 240 Rue Evariste Galois06410 Biot, France\n\n**Arteris Paris** 251 Rue du Faubourg Saint-Martin75010 Paris, France+33 1 40 21 35 50\n\n#### Asia\n\n**Arteris Nanjing** Room 2708, Yunfeng MansionNo. 8 Zhongshan North RoadNanjing, China, 210038安通思半导体技术（南京）有限公司南京市鼓楼区中山北路8号云峰大厦2708室邮编 210008\n\n**Arteris Seoul** U-Space 2B, #1001,670, Daewangpangyo-ro Bundang-gu, Seongnam-si, Gyeonggi-do, Seoul 13494 Korea+82 (10) 4704 9526\n\n**Arteris Tokyo** #402, 2-10-15 Shibuya, Shibuya-kuTokyo, Japan 150-0002+81 3 4405 0399\n\n#### Support\n\nNeed help? Visit the [helpdesk](https://arterisip.atlassian.net/servicedesk)Semiconductor IP: help@arteris.comIP Deployment: mds_service_desk@arteris.com\n\n### Connect With Us\n\n[](https://twitter.com/arteris_noc) [](https://www.linkedin.com/company/30628)\n\n### Legal\n\n[Terms of Use](https://www.arteris.com/terms-of-use) [Privacy Policy](https://www.arteris.com/privacy) [Trademarks & Copyrights](https://www.arteris.com/legal/trademarks) [Trademark Usage Guidelines](https://www.arteris.com/en/trademarks-guidelines) [Manage My Privacy](https://privacyportal.onetrust.com/webform/10c5e60f-f275-434d-944b-42efe82f6bf2/ef35fd8d-582f-418e-840e-1f0f29f2f3e8) [Do Not Sell/Share My Information](https://privacyportal.onetrust.com/webform/10c5e60f-f275-434d-944b-42efe82f6bf2/ef35fd8d-582f-418e-840e-1f0f29f2f3e8)\n\nCopyright © 2004-2024 Arteris, Inc. and its affiliates. All rights reserved. Modification or reproduction in any form whatsoever, without prior written consent of Arteris, Inc. or its designated affiliate(s), is strictly forbidden. \n\n[](# \"Back to Top\")\n"
        },
        {
          "title": "Quarterly Results",
          "url": "https://ir.arteris.com/financial-information/quarterly-results",
          "content": "[ Skip to main navigation ](#main-menu)\n\n[ ![logo](/sites/g/files/knoqqb68011/themes/site/nir_pid5384/dist/images/Arteris_logo_bk_org_rgb.svg) ](https://www.arteris.com/)\n\n  * [Home](/ \"Main Investor Relations Page\")\n  * [Press Releases](/news-events/news-releases)\n  * [Events and Presentations](/events-and-presentations)\n  * [Corporate Governance](/corporate-governance/governance-overview)\n    * [Governance Overview](/corporate-governance/governance-overview)\n    * [Board of Directors](https://www.arteris.com/about-arteris/leadership/#Board-of-Directors)\n    * [Management](https://www.arteris.com/management)\n    * [Committee Composition](/corporate-governance/committee-composition)\n  * [Financial Information](/financial-information/sec-filings)\n    * [SEC Filings](/financial-information/sec-filings)\n    * [Quarterly Results](/financial-information/quarterly-results)\n  * [Stock Information](/stock-information/stock-quote-chart)\n    * [Stock Quote & Chart](/stock-information/stock-quote-chart)\n    * [Analyst Coverage](/financial-information/analyst-coverage)\n  * [IR Resources](/shareholder-services/investor-faqs)\n    * [Investor FAQs](/shareholder-services/investor-faqs)\n    * [Email Alerts](/shareholder-services/email-alerts)\n    * [Contact IR](/shareholder-services/contact-ir)\n\n\n\n#  Quarterly Results \n\n[Show all](#)\n\n## 2024\n\nThird Quarter 2024 Financial Results \n\n  * [Arteris, Inc. Third Quarter 2024 Earnings Conference Call](/events/event-details/arteris-inc-third-quarter-2024-earnings-conference-call \"Arteris, Inc. Third Quarter 2024 Earnings Conference Call\")\n\n  * [Arteris Announces Financial Results for the Third Quarter 2024 and Fourth Quarter and Full Year 2024 Guidance](/news-releases/news-release-details/arteris-announces-financial-results-third-quarter-2024-and \"Arteris Announces Financial Results for the Third Quarter 2024 and Fourth Quarter and Full Year 2024 Guidance\")\n\n  * [Form 10-Q](/sec-filings/sec-filing/10-q/0001667011-24-000036 \"Form 10-Q\")\n\n\n\n\nSecond Quarter 2024 Financial Results \n\n  * [Arteris, Inc. Second Quarter 2024 Earnings Conference Call](/events/event-details/arteris-inc-second-quarter-2024-earnings-conference-call \"Arteris, Inc. Second Quarter 2024 Earnings Conference Call\")\n\n  * [Arteris Announces Financial Results for the Second Quarter 2024 and Third Quarter and Full Year 2024 Guidance](/news-releases/news-release-details/arteris-announces-financial-results-second-quarter-2024-and \"Arteris Announces Financial Results for the Second Quarter 2024 and Third Quarter and Full Year 2024 Guidance\")\n\n  * [Form 10-Q](/sec-filings/sec-filing/10-q/0001667011-24-000026 \"Form 10-Q\")\n\n\n\n\nFirst Quarter 2024 Financial Results \n\n  * [Arteris, Inc. First Quarter 2024 Earnings Conference Call](/events/event-details/arteris-inc-first-quarter-2024-earnings-conference-call \"Arteris, Inc. First Quarter 2024 Earnings Conference Call\")\n\n  * [Arteris Announces Financial Results for the First Quarter 2024 and Second Quarter and Full Year 2024 Guidance](/news-releases/news-release-details/arteris-announces-financial-results-first-quarter-2024-and \"Arteris Announces Financial Results for the First Quarter 2024 and Second Quarter and Full Year 2024 Guidance\")\n\n  * [Form 10-Q](/sec-filings/sec-filing/10-q/0001667011-24-000016 \"Form 10-Q\")\n\n\n\n\n## 2023\n\nFourth Quarter 2023 Financial Results \n\n  * [Arteris, Inc. Fourth Quarter 2023 Earnings Conference Call](/events/event-details/arteris-inc-fourth-quarter-2023-earnings-conference-call \"Arteris, Inc. Fourth Quarter 2023 Earnings Conference Call\")\n\n  * [Arteris Announces Financial Results for the Fourth Quarter and Full Year 2023 and Estimated First Quarter and Full Year 2024 Guidance](/news-releases/news-release-details/arteris-announces-financial-results-fourth-quarter-and-full-1 \"Arteris Announces Financial Results for the Fourth Quarter and Full Year 2023 and Estimated First Quarter and Full Year 2024 Guidance\")\n\n  * [Form 10-K](/sec-filings/sec-filing/10-k/0001667011-24-000010 \"Form 10-K\")\n\n\n\n\nThird Quarter 2023 Financial Results \n\n  * [Arteris, Inc. Third Quarter 2023 Earnings Conference Call](/events/event-details/arteris-inc-third-quarter-2023-earnings-conference-call \"Arteris, Inc. Third Quarter 2023 Earnings Conference Call\")\n\n  * [Arteris Announces Financial Results for the Third Quarter 2023 and Fourth Quarter and Full Year 2023 Guidance](/news-releases/news-release-details/arteris-announces-financial-results-third-quarter-2023-and \"Arteris Announces Financial Results for the Third Quarter 2023 and Fourth Quarter and Full Year 2023 Guidance\")\n\n  * [Form 10-Q](/sec-filings/sec-filing/10-q/0001667011-23-000030 \"Form 10-Q\")\n\n\n\n\nSecond Quarter 2023 Financial Results \n\n  * [Arteris, Inc. Second Quarter 2023 Earnings Conference Call](/events/event-details/arteris-inc-second-quarter-2023-earnings-conference-call \"Arteris, Inc. Second Quarter 2023 Earnings Conference Call\")\n\n  * [Arteris Announces Financial Results for the Second Quarter 2023 and Estimated Third Quarter and Full Year 2023 Guidance](/news-releases/news-release-details/arteris-announces-financial-results-second-quarter-2023-and \"Arteris Announces Financial Results for the Second Quarter 2023 and Estimated Third Quarter and Full Year 2023 Guidance\")\n\n  * [Form 10-Q](/sec-filings/sec-filing/10-q/0001667011-23-000022 \"Form 10-Q\")\n\n\n\n\nFirst Quarter 2023 Financial Results \n\n  * [Arteris, Inc. First Quarter 2023 Earnings Conference Call](/events/event-details/arteris-inc-first-quarter-2023-earnings-conference-call \"Arteris, Inc. First Quarter 2023 Earnings Conference Call\")\n\n  * [Arteris Announces Financial Results for the First Quarter 2023 and Estimated Second Quarter and Full Year 2023 Guidance](/news-releases/news-release-details/arteris-announces-financial-results-first-quarter-2023-and \"Arteris Announces Financial Results for the First Quarter 2023 and Estimated Second Quarter and Full Year 2023 Guidance\")\n\n  * [Form 10-Q](/sec-filings/sec-filing/10-q/0001667011-23-000015 \"Form 10-Q\")\n\n\n\n\n## 2022\n\nFourth Quarter 2022 Financial Results \n\n  * [Arteris, Inc. Fourth Quarter 2022 Earnings Conference Call](/events/event-details/arteris-inc-fourth-quarter-2022-earnings-conference-call \"Arteris, Inc. Fourth Quarter 2022 Earnings Conference Call\")\n\n  * [Arteris Announces Financial Results for the Fourth Quarter and Full Year 2022 and Estimated First Quarter and Full Year 2023 Guidance](/news-releases/news-release-details/arteris-announces-financial-results-fourth-quarter-and-full-0 \"Arteris Announces Financial Results for the Fourth Quarter and Full Year 2022 and Estimated First Quarter and Full Year 2023 Guidance\")\n\n  * [Form 10-K](/sec-filings/sec-filing/10-k/0001667011-23-000009 \"Form 10-K\")\n\n\n\n\nThird Quarter 2022 Financial Results \n\n  * [Arteris, Inc. Third Quarter 2022 Earnings Conference Call](/events/event-details/arteris-inc-third-quarter-2022-earnings-conference-call \"Arteris, Inc. Third Quarter 2022 Earnings Conference Call\")\n\n  * [Arteris Announces Financial Results for the Third Quarter 2022 and Estimated Fourth Quarter and Full Year 2022 Guidance](/news-releases/news-release-details/arteris-announces-financial-results-third-quarter-2022-and \"Arteris Announces Financial Results for the Third Quarter 2022 and Estimated Fourth Quarter and Full Year 2022 Guidance\")\n\n  * [Form 10-Q](/sec-filings/sec-filing/10-q/0001667011-22-000036 \"Form 10-Q\")\n\n\n\n\nSecond Quarter 2022 Financial Results \n\n  * [Arteris, Inc. Second Quarter 2022 Earnings Conference Call](/events/event-details/arteris-inc-second-quarter-2022-earnings-conference-call \"Arteris, Inc. Second Quarter 2022 Earnings Conference Call\")\n\n  * [Arteris Announces Financial Results for the Second Quarter 2022 and Estimated Third Quarter and Full Year 2022 Guidance](/news-releases/news-release-details/arteris-announces-financial-results-second-quarter-2022-and \"Arteris Announces Financial Results for the Second Quarter 2022 and Estimated Third Quarter and Full Year 2022 Guidance\")\n\n  * [Form 10-Q](/sec-filings/sec-filing/10-q/0001667011-22-000027 \"Form 10-Q\")\n\n\n\n\nFirst Quarter 2022 Financial Results \n\n  * [Arteris, Inc. First Quarter 2022 Earnings Conference Call](/events/event-details/arteris-inc-first-quarter-2022-earnings-conference-call \"Arteris, Inc. First Quarter 2022 Earnings Conference Call\")\n\n  * [Arteris Announces Financial Results for the First Quarter 2022 and Estimated Second Quarter and Full Year 2022 Guidance](/news-releases/news-release-details/arteris-announces-financial-results-first-quarter-2022-and \"Arteris Announces Financial Results for the First Quarter 2022 and Estimated Second Quarter and Full Year 2022 Guidance\")\n\n  * [Form 10-Q](/sec-filings/sec-filing/10-q/0001667011-22-000019 \"Form 10-Q\")\n\n\n\n\n## 2021\n\nFourth Quarter 2021 Financial Results \n\n  * [Arteris, Inc. Fourth Quarter 2021 Earnings Conference Call](/events/event-details/arteris-inc-fourth-quarter-2021-earnings-conference-call \"Arteris, Inc. Fourth Quarter 2021 Earnings Conference Call\")\n\n  * [Arteris Announces Financial Results for the Fourth Quarter and Full Year 2021 and Estimated First Quarter and Full Year 2022 Guidance](/news-releases/news-release-details/arteris-announces-financial-results-fourth-quarter-and-full-year \"Arteris Announces Financial Results for the Fourth Quarter and Full Year 2021 and Estimated First Quarter and Full Year 2022 Guidance\")\n\n  * [Form 10-K](/sec-filings/sec-filing/10-k/0001667011-22-000010 \"Form 10-K\")\n\n\n\n\nThird Quarter 2021 Financial Results \n\n  * [Arteris, Inc. Third Quarter 2021 Earnings Conference Call](/events/event-details/arteris-inc-third-quarter-2021-earnings-conference-call \"Arteris, Inc. Third Quarter 2021 Earnings Conference Call\")\n\n  * [Arteris Announces Financial Results for the Third Quarter 2021 and Estimated Fourth Quarter and Full Year 2021 Guidance](/news-releases/news-release-details/arteris-announces-financial-results-third-quarter-2021-and \"Arteris Announces Financial Results for the Third Quarter 2021 and Estimated Fourth Quarter and Full Year 2021 Guidance\")\n\n  * [Form 10-Q](/sec-filings/sec-filing/10-q/0001667011-21-000008 \"Form 10-Q\")\n\n\n\n\nRequest Email Alerts\n\n### Contact\n\n#### Americas\n\n**Arteris Headquarters** 900 E. Hamilton Avenue, Suite 300Campbell, CA 95008 USA+1 408 470 7300Contact: info@arteris.com\n\n**Arteris Austin** 9601 Amberglen Blvd, Suite 117Austin, TX 78729 USA\n\n#### Europe\n\n**Arteris Montigny** 2 Rue George Stephenson78180 Montigny le Bretonneux, France+33 1 61 37 38 40\n\n**Arteris Nice** 240 Rue Evariste Galois06410 Biot, France\n\n**Arteris Paris** 251 Rue du Faubourg Saint-Martin75010 Paris, France+33 1 40 21 35 50\n\n#### Asia\n\n**Arteris Nanjing** Room 2708, Yunfeng MansionNo. 8 Zhongshan North RoadNanjing, China, 210038安通思半导体技术（南京）有限公司南京市鼓楼区中山北路8号云峰大厦2708室邮编 210008\n\n**Arteris Seoul** U-Space 2B, #1001,670, Daewangpangyo-ro Bundang-gu, Seongnam-si, Gyeonggi-do, Seoul 13494 Korea+82 (10) 4704 9526\n\n**Arteris Tokyo** #402, 2-10-15 Shibuya, Shibuya-kuTokyo, Japan 150-0002+81 3 4405 0399\n\n#### Support\n\nNeed help? Visit the [helpdesk](https://arterisip.atlassian.net/servicedesk)Semiconductor IP: help@arteris.comIP Deployment: mds_service_desk@arteris.com\n\n### Connect With Us\n\n[](https://twitter.com/arteris_noc) [](https://www.linkedin.com/company/30628)\n\n### Legal\n\n[Terms of Use](https://www.arteris.com/terms-of-use) [Privacy Policy](https://www.arteris.com/privacy) [Trademarks & Copyrights](https://www.arteris.com/legal/trademarks) [Trademark Usage Guidelines](https://www.arteris.com/en/trademarks-guidelines) [Manage My Privacy](https://privacyportal.onetrust.com/webform/10c5e60f-f275-434d-944b-42efe82f6bf2/ef35fd8d-582f-418e-840e-1f0f29f2f3e8) [Do Not Sell/Share My Information](https://privacyportal.onetrust.com/webform/10c5e60f-f275-434d-944b-42efe82f6bf2/ef35fd8d-582f-418e-840e-1f0f29f2f3e8)\n\nCopyright © 2004-2024 Arteris, Inc. and its affiliates. All rights reserved. Modification or reproduction in any form whatsoever, without prior written consent of Arteris, Inc. or its designated affiliate(s), is strictly forbidden. \n\n[](# \"Back to Top\")\n"
        }
      ]
    },
    {
      "section_name": "IR Resources",
      "links": [
        {
          "title": "Investor FAQs",
          "url": "https://ir.arteris.com/shareholder-services/investor-faqs",
          "content": "[ Skip to main navigation ](#main-menu)\n\n[ ![logo](/sites/g/files/knoqqb68011/themes/site/nir_pid5384/dist/images/Arteris_logo_bk_org_rgb.svg) ](https://www.arteris.com/)\n\n  * [Home](/ \"Main Investor Relations Page\")\n  * [Press Releases](/news-events/news-releases)\n  * [Events and Presentations](/events-and-presentations)\n  * [Corporate Governance](/corporate-governance/governance-overview)\n    * [Governance Overview](/corporate-governance/governance-overview)\n    * [Board of Directors](https://www.arteris.com/about-arteris/leadership/#Board-of-Directors)\n    * [Management](https://www.arteris.com/management)\n    * [Committee Composition](/corporate-governance/committee-composition)\n  * [Financial Information](/financial-information/sec-filings)\n    * [SEC Filings](/financial-information/sec-filings)\n    * [Quarterly Results](/financial-information/quarterly-results)\n  * [Stock Information](/stock-information/stock-quote-chart)\n    * [Stock Quote & Chart](/stock-information/stock-quote-chart)\n    * [Analyst Coverage](/financial-information/analyst-coverage)\n  * [IR Resources](/shareholder-services/investor-faqs)\n    * [Investor FAQs](/shareholder-services/investor-faqs)\n    * [Email Alerts](/shareholder-services/email-alerts)\n    * [Contact IR](/shareholder-services/contact-ir)\n\n\n\n#  Investor FAQs \n\n[Show All](#)\n\nWhere is Arteris, Inc.’s corporate headquarters?\n\nArteris, Inc.’s corporate headquarters is located at 900 E. Hamilton Avenue, Suite 300, Campbell, CA 95008\n\nWhen was Arteris, Inc. founded?\n\ni. Arteris, Inc. was founded originally as a U.S. subsidiary of Arteris SA, in April 2004; ii. Arteris, Inc. later became the headquarters of Arteris IP after corporate reorganization by February 2016.\n\nWhen did Arteris, Inc. go public? What was the price?\n\nArteris, Inc completed its initial public offering on October 26, 2021 at a share price of $14.00.\n\nWhat is Arteris, Inc.’s fiscal year?\n\nArteris, Inc.’s fiscal year is based on the calendar year. The last day of the fiscal year is December 31st.\n\nOn what stock exchange is Arteris, Inc.traded and under what symbol?\n\nArteris, Inc. is traded on Nasdaq under the ticker symbol AIP\n\nDoes Arteris, Inc. declare or issue dividends?\n\nArteris, Inc has not declared or paid cash dividends on its common stock to date.\n\nWhere does Arteris, Inc. hold its cash and short term investments?\n\nAt fiscal year-end December 31, 2022, Arteris, Inc. had approximately $68.3 million in cash and short-term investments, and $4.4 million in long-term investments. Arteris, Inc. has a robust treasury strategy that is designed to diversify risk across multiple financial institutions, with nearly all of our funds held in large global institutions, all of which have investment grade ratings equivalent to Aa- or better. Arteris, Inc. has no financial institution debt.\n\nWho is Arteris, Inc.’s transfer agent?\n\nAmerican Stock Transfer & Trust Company AST Shareholder Services Call Center Toll Free: +1.800.937.5449 Local & International: +1.718.921.8124 help@astfinancial.com Hours: 8 a.m. – 8 p.m. ET Monday-Friday\n\nHow do I invest in Arteris, Inc.?\n\nInterested investors should consult a stockbroker to invest.\n\nWho are Arteris, Inc.'s independent accountants?\n\nMoss Adams LLP 635 Campbell Technology Parkway Campbell, CA 95008\n\nWhom should I contact regarding investor inquiries?\n\nFor investor-related questions please contact: Erica Mannion or Mike Funari Sapphire Investor Relations, LLC Phone: +1 617-542-6180 E-mail: IR@Arteris.com\n\nRequest Email Alerts\n\n### Contact\n\n#### Americas\n\n**Arteris Headquarters** 900 E. Hamilton Avenue, Suite 300Campbell, CA 95008 USA+1 408 470 7300Contact: info@arteris.com\n\n**Arteris Austin** 9601 Amberglen Blvd, Suite 117Austin, TX 78729 USA\n\n#### Europe\n\n**Arteris Montigny** 2 Rue George Stephenson78180 Montigny le Bretonneux, France+33 1 61 37 38 40\n\n**Arteris Nice** 240 Rue Evariste Galois06410 Biot, France\n\n**Arteris Paris** 251 Rue du Faubourg Saint-Martin75010 Paris, France+33 1 40 21 35 50\n\n#### Asia\n\n**Arteris Nanjing** Room 2708, Yunfeng MansionNo. 8 Zhongshan North RoadNanjing, China, 210038安通思半导体技术（南京）有限公司南京市鼓楼区中山北路8号云峰大厦2708室邮编 210008\n\n**Arteris Seoul** U-Space 2B, #1001,670, Daewangpangyo-ro Bundang-gu, Seongnam-si, Gyeonggi-do, Seoul 13494 Korea+82 (10) 4704 9526\n\n**Arteris Tokyo** #402, 2-10-15 Shibuya, Shibuya-kuTokyo, Japan 150-0002+81 3 4405 0399\n\n#### Support\n\nNeed help? Visit the [helpdesk](https://arterisip.atlassian.net/servicedesk)Semiconductor IP: help@arteris.comIP Deployment: mds_service_desk@arteris.com\n\n### Connect With Us\n\n[](https://twitter.com/arteris_noc) [](https://www.linkedin.com/company/30628)\n\n### Legal\n\n[Terms of Use](https://www.arteris.com/terms-of-use) [Privacy Policy](https://www.arteris.com/privacy) [Trademarks & Copyrights](https://www.arteris.com/legal/trademarks) [Trademark Usage Guidelines](https://www.arteris.com/en/trademarks-guidelines) [Manage My Privacy](https://privacyportal.onetrust.com/webform/10c5e60f-f275-434d-944b-42efe82f6bf2/ef35fd8d-582f-418e-840e-1f0f29f2f3e8) [Do Not Sell/Share My Information](https://privacyportal.onetrust.com/webform/10c5e60f-f275-434d-944b-42efe82f6bf2/ef35fd8d-582f-418e-840e-1f0f29f2f3e8)\n\nCopyright © 2004-2024 Arteris, Inc. and its affiliates. All rights reserved. Modification or reproduction in any form whatsoever, without prior written consent of Arteris, Inc. or its designated affiliate(s), is strictly forbidden. \n\n[](# \"Back to Top\")\n\nThis website stores cookies on your computer. These cookies are used to collect information about how you interact with our website and allow us to remember you. We use this information in order to improve and customize your browsing experience and for analytics and metrics about our visitors both on this website and other media. To find out more about the cookies we use, see our[Privacy Policy](https://www.arteris.com/privacy/)\n\nAccept All Cookies\n\nManage Cookies\n\n![Arteris logo](https://cdn.cookielaw.org/logos/10c5e60f-f275-434d-944b-42efe82f6bf2/ec3fa55b-bcc3-4e07-a809-7d718a6bcde9/238882af-4102-4fd3-8930-4af49e9ab198/arteris-logo.png)\n\n## Privacy Preference Center\n\nWhen you visit any website, it may store or retrieve information on your browser, mostly in the form of cookies. This information might be about you, your preferences or your device and is mostly used to make the site work as you expect it to. The information does not usually directly identify you, but it can give you a more personalized web experience. Because we respect your right to privacy, you can choose not to allow some types of cookies. Click on the different category headings to find out more and change our default settings. However, blocking some types of cookies may impact your experience of the site and the services we are able to offer. [Privacy Policy](https://www.arteris.com/privacy/)\n\nAllow All\n\n###  Manage Consent Preferences\n\n#### Strictly Necessary Cookies\n\nAlways Active\n\nThese cookies are necessary for the website to function and cannot be switched off in our systems. They are usually only set in response to actions made by you which amount to a request for services, such as setting your privacy preferences, logging in or filling in forms. You can set your browser to block or alert you about these cookies, but some parts of the site will not then work. These cookies do not store any personally identifiable information.\n\n#### Functional Cookies\n\nFunctional Cookies\n\nThese cookies enable the website to provide enhanced functionality and personalization. They may be set by us or by third party providers whose services we have added to our pages. If you do not allow these cookies then some or all of these services may not function properly.\n\n#### Performance Cookies\n\nPerformance Cookies\n\nThese cookies allow us to count visits and traffic sources so we can measure and improve the performance of our site. They help us to know which pages are the most and least popular and see how visitors move around the site. All information these cookies collect is aggregated and therefore anonymous. If you do not allow these cookies we will not know when you have visited our site, and will not be able to monitor its performance.\n\n#### Targeting Cookies\n\nTargeting Cookies\n\nThese cookies may be set through our site by our advertising partners. They may be used by those companies to build a profile of your interests and show you relevant adverts on other sites. They do not store directly personal information, but are based on uniquely identifying your browser and internet device. If you do not allow these cookies, you will experience less targeted advertising.\n\nBack Button\n\n### Cookie List\n\nSearch Icon\n\nFilter Icon\n\nClear\n\ncheckbox label label\n\nApply Cancel\n\nConsent Leg.Interest\n\ncheckbox label label\n\ncheckbox label label\n\ncheckbox label label\n\nOnly Essential Cookies Confirm My Choices\n\n[![Powered by Onetrust](https://cdn.cookielaw.org/logos/static/powered_by_logo.svg)](https://www.onetrust.com/products/cookie-consent/)\n"
        },
        {
          "title": "Email Alerts",
          "url": "https://ir.arteris.com/shareholder-services/email-alerts",
          "content": "[ Skip to main navigation ](#main-menu)\n\n[ ![logo](/sites/g/files/knoqqb68011/themes/site/nir_pid5384/dist/images/Arteris_logo_bk_org_rgb.svg) ](https://www.arteris.com/)\n\n  * [Home](/ \"Main Investor Relations Page\")\n  * [Press Releases](/news-events/news-releases)\n  * [Events and Presentations](/events-and-presentations)\n  * [Corporate Governance](/corporate-governance/governance-overview)\n    * [Governance Overview](/corporate-governance/governance-overview)\n    * [Board of Directors](https://www.arteris.com/about-arteris/leadership/#Board-of-Directors)\n    * [Management](https://www.arteris.com/management)\n    * [Committee Composition](/corporate-governance/committee-composition)\n  * [Financial Information](/financial-information/sec-filings)\n    * [SEC Filings](/financial-information/sec-filings)\n    * [Quarterly Results](/financial-information/quarterly-results)\n  * [Stock Information](/stock-information/stock-quote-chart)\n    * [Stock Quote & Chart](/stock-information/stock-quote-chart)\n    * [Analyst Coverage](/financial-information/analyst-coverage)\n  * [IR Resources](/shareholder-services/investor-faqs)\n    * [Investor FAQs](/shareholder-services/investor-faqs)\n    * [Email Alerts](/shareholder-services/email-alerts)\n    * [Contact IR](/shareholder-services/contact-ir)\n\n\n\n#  Email Alerts \n\nRequired fields denoted by an asterisk ().\n\nHide lower priority columns\n\nAlert type  \n---  \nQuote  \nSEC Filing  \nEvent  \nNews  \n  \nEmail\n\nFirst Name\n\nLast Name\n\nTitle\n\nCompany\n\nInvestor type - Select -Individual InvestorBuy-Side AnalystSell-Side AnalystPortfolio ManagerStock BrokerEmployeeNews MediaLibraryOther\n\n- Select -\n\nLeave this field blank\n\nRequest Email Alerts\n\n### Contact\n\n#### Americas\n\n**Arteris Headquarters** 900 E. Hamilton Avenue, Suite 300Campbell, CA 95008 USA+1 408 470 7300Contact: info@arteris.com\n\n**Arteris Austin** 9601 Amberglen Blvd, Suite 117Austin, TX 78729 USA\n\n#### Europe\n\n**Arteris Montigny** 2 Rue George Stephenson78180 Montigny le Bretonneux, France+33 1 61 37 38 40\n\n**Arteris Nice** 240 Rue Evariste Galois06410 Biot, France\n\n**Arteris Paris** 251 Rue du Faubourg Saint-Martin75010 Paris, France+33 1 40 21 35 50\n\n#### Asia\n\n**Arteris Nanjing** Room 2708, Yunfeng MansionNo. 8 Zhongshan North RoadNanjing, China, 210038安通思半导体技术（南京）有限公司南京市鼓楼区中山北路8号云峰大厦2708室邮编 210008\n\n**Arteris Seoul** U-Space 2B, #1001,670, Daewangpangyo-ro Bundang-gu, Seongnam-si, Gyeonggi-do, Seoul 13494 Korea+82 (10) 4704 9526\n\n**Arteris Tokyo** #402, 2-10-15 Shibuya, Shibuya-kuTokyo, Japan 150-0002+81 3 4405 0399\n\n#### Support\n\nNeed help? Visit the [helpdesk](https://arterisip.atlassian.net/servicedesk)Semiconductor IP: help@arteris.comIP Deployment: mds_service_desk@arteris.com\n\n### Connect With Us\n\n[](https://twitter.com/arteris_noc) [](https://www.linkedin.com/company/30628)\n\n### Legal\n\n[Terms of Use](https://www.arteris.com/terms-of-use) [Privacy Policy](https://www.arteris.com/privacy) [Trademarks & Copyrights](https://www.arteris.com/legal/trademarks) [Trademark Usage Guidelines](https://www.arteris.com/en/trademarks-guidelines) [Manage My Privacy](https://privacyportal.onetrust.com/webform/10c5e60f-f275-434d-944b-42efe82f6bf2/ef35fd8d-582f-418e-840e-1f0f29f2f3e8) [Do Not Sell/Share My Information](https://privacyportal.onetrust.com/webform/10c5e60f-f275-434d-944b-42efe82f6bf2/ef35fd8d-582f-418e-840e-1f0f29f2f3e8)\n\nCopyright © 2004-2024 Arteris, Inc. and its affiliates. All rights reserved. Modification or reproduction in any form whatsoever, without prior written consent of Arteris, Inc. or its designated affiliate(s), is strictly forbidden. \n\n[](# \"Back to Top\")\n\nThis website stores cookies on your computer. These cookies are used to collect information about how you interact with our website and allow us to remember you. We use this information in order to improve and customize your browsing experience and for analytics and metrics about our visitors both on this website and other media. To find out more about the cookies we use, see our[Privacy Policy](https://www.arteris.com/privacy/)\n\nAccept All Cookies\n\nManage Cookies\n\n![Arteris logo](https://cdn.cookielaw.org/logos/10c5e60f-f275-434d-944b-42efe82f6bf2/ec3fa55b-bcc3-4e07-a809-7d718a6bcde9/238882af-4102-4fd3-8930-4af49e9ab198/arteris-logo.png)\n\n## Privacy Preference Center\n\nWhen you visit any website, it may store or retrieve information on your browser, mostly in the form of cookies. This information might be about you, your preferences or your device and is mostly used to make the site work as you expect it to. The information does not usually directly identify you, but it can give you a more personalized web experience. Because we respect your right to privacy, you can choose not to allow some types of cookies. Click on the different category headings to find out more and change our default settings. However, blocking some types of cookies may impact your experience of the site and the services we are able to offer. [Privacy Policy](https://www.arteris.com/privacy/)\n\nAllow All\n\n###  Manage Consent Preferences\n\n#### Strictly Necessary Cookies\n\nAlways Active\n\nThese cookies are necessary for the website to function and cannot be switched off in our systems. They are usually only set in response to actions made by you which amount to a request for services, such as setting your privacy preferences, logging in or filling in forms. You can set your browser to block or alert you about these cookies, but some parts of the site will not then work. These cookies do not store any personally identifiable information.\n\n#### Functional Cookies\n\nFunctional Cookies\n\nThese cookies enable the website to provide enhanced functionality and personalization. They may be set by us or by third party providers whose services we have added to our pages. If you do not allow these cookies then some or all of these services may not function properly.\n\n#### Performance Cookies\n\nPerformance Cookies\n\nThese cookies allow us to count visits and traffic sources so we can measure and improve the performance of our site. They help us to know which pages are the most and least popular and see how visitors move around the site. All information these cookies collect is aggregated and therefore anonymous. If you do not allow these cookies we will not know when you have visited our site, and will not be able to monitor its performance.\n\n#### Targeting Cookies\n\nTargeting Cookies\n\nThese cookies may be set through our site by our advertising partners. They may be used by those companies to build a profile of your interests and show you relevant adverts on other sites. They do not store directly personal information, but are based on uniquely identifying your browser and internet device. If you do not allow these cookies, you will experience less targeted advertising.\n\nBack Button\n\n### Cookie List\n\nSearch Icon\n\nFilter Icon\n\nClear\n\ncheckbox label label\n\nApply Cancel\n\nConsent Leg.Interest\n\ncheckbox label label\n\ncheckbox label label\n\ncheckbox label label\n\nOnly Essential Cookies Confirm My Choices\n\n[![Powered by Onetrust](https://cdn.cookielaw.org/logos/static/powered_by_logo.svg)](https://www.onetrust.com/products/cookie-consent/)\n"
        },
        {
          "title": "Contact IR",
          "url": "https://ir.arteris.com/shareholder-services/contact-ir",
          "content": "[ Skip to main navigation ](#main-menu)\n\n[ ![logo](/sites/g/files/knoqqb68011/themes/site/nir_pid5384/dist/images/Arteris_logo_bk_org_rgb.svg) ](https://www.arteris.com/)\n\n  * [Home](/ \"Main Investor Relations Page\")\n  * [Press Releases](/news-events/news-releases)\n  * [Events and Presentations](/events-and-presentations)\n  * [Corporate Governance](/corporate-governance/governance-overview)\n    * [Governance Overview](/corporate-governance/governance-overview)\n    * [Board of Directors](https://www.arteris.com/about-arteris/leadership/#Board-of-Directors)\n    * [Management](https://www.arteris.com/management)\n    * [Committee Composition](/corporate-governance/committee-composition)\n  * [Financial Information](/financial-information/sec-filings)\n    * [SEC Filings](/financial-information/sec-filings)\n    * [Quarterly Results](/financial-information/quarterly-results)\n  * [Stock Information](/stock-information/stock-quote-chart)\n    * [Stock Quote & Chart](/stock-information/stock-quote-chart)\n    * [Analyst Coverage](/financial-information/analyst-coverage)\n  * [IR Resources](/shareholder-services/investor-faqs)\n    * [Investor FAQs](/shareholder-services/investor-faqs)\n    * [Email Alerts](/shareholder-services/email-alerts)\n    * [Contact IR](/shareholder-services/contact-ir)\n\n\n\n#  Contact IR \n\n## Contact IR\n\n**For Investor Relations:** Erica Mannion or Mike Funari Sapphire Investor Relations, LLC Phone: +1 617-542-6180 E-mail: IR@Arteris.com\n\n**For Transfer Agent:** American Stock Transfer & Trust Company AST Shareholder Services Call Center Toll Free: +1.800.937.5449 Local & International: +1.718.921.8124 help@astfinancial.com Hours: 8 a.m. - 8 p.m. ET Monday-Friday\n\nRequest Email Alerts\n\n### Contact\n\n#### Americas\n\n**Arteris Headquarters** 900 E. Hamilton Avenue, Suite 300Campbell, CA 95008 USA+1 408 470 7300Contact: info@arteris.com\n\n**Arteris Austin** 9601 Amberglen Blvd, Suite 117Austin, TX 78729 USA\n\n#### Europe\n\n**Arteris Montigny** 2 Rue George Stephenson78180 Montigny le Bretonneux, France+33 1 61 37 38 40\n\n**Arteris Nice** 240 Rue Evariste Galois06410 Biot, France\n\n**Arteris Paris** 251 Rue du Faubourg Saint-Martin75010 Paris, France+33 1 40 21 35 50\n\n#### Asia\n\n**Arteris Nanjing** Room 2708, Yunfeng MansionNo. 8 Zhongshan North RoadNanjing, China, 210038安通思半导体技术（南京）有限公司南京市鼓楼区中山北路8号云峰大厦2708室邮编 210008\n\n**Arteris Seoul** U-Space 2B, #1001,670, Daewangpangyo-ro Bundang-gu, Seongnam-si, Gyeonggi-do, Seoul 13494 Korea+82 (10) 4704 9526\n\n**Arteris Tokyo** #402, 2-10-15 Shibuya, Shibuya-kuTokyo, Japan 150-0002+81 3 4405 0399\n\n#### Support\n\nNeed help? Visit the [helpdesk](https://arterisip.atlassian.net/servicedesk)Semiconductor IP: help@arteris.comIP Deployment: mds_service_desk@arteris.com\n\n### Connect With Us\n\n[](https://twitter.com/arteris_noc) [](https://www.linkedin.com/company/30628)\n\n### Legal\n\n[Terms of Use](https://www.arteris.com/terms-of-use) [Privacy Policy](https://www.arteris.com/privacy) [Trademarks & Copyrights](https://www.arteris.com/legal/trademarks) [Trademark Usage Guidelines](https://www.arteris.com/en/trademarks-guidelines) [Manage My Privacy](https://privacyportal.onetrust.com/webform/10c5e60f-f275-434d-944b-42efe82f6bf2/ef35fd8d-582f-418e-840e-1f0f29f2f3e8) [Do Not Sell/Share My Information](https://privacyportal.onetrust.com/webform/10c5e60f-f275-434d-944b-42efe82f6bf2/ef35fd8d-582f-418e-840e-1f0f29f2f3e8)\n\nCopyright © 2004-2024 Arteris, Inc. and its affiliates. All rights reserved. Modification or reproduction in any form whatsoever, without prior written consent of Arteris, Inc. or its designated affiliate(s), is strictly forbidden. \n\n[](# \"Back to Top\")\n\nThis website stores cookies on your computer. These cookies are used to collect information about how you interact with our website and allow us to remember you. We use this information in order to improve and customize your browsing experience and for analytics and metrics about our visitors both on this website and other media. To find out more about the cookies we use, see our[Privacy Policy](https://www.arteris.com/privacy/)\n\nAccept All Cookies\n\nManage Cookies\n\n![Arteris logo](https://cdn.cookielaw.org/logos/10c5e60f-f275-434d-944b-42efe82f6bf2/ec3fa55b-bcc3-4e07-a809-7d718a6bcde9/238882af-4102-4fd3-8930-4af49e9ab198/arteris-logo.png)\n\n## Privacy Preference Center\n\nWhen you visit any website, it may store or retrieve information on your browser, mostly in the form of cookies. This information might be about you, your preferences or your device and is mostly used to make the site work as you expect it to. The information does not usually directly identify you, but it can give you a more personalized web experience. Because we respect your right to privacy, you can choose not to allow some types of cookies. Click on the different category headings to find out more and change our default settings. However, blocking some types of cookies may impact your experience of the site and the services we are able to offer. [Privacy Policy](https://www.arteris.com/privacy/)\n\nAllow All\n\n###  Manage Consent Preferences\n\n#### Strictly Necessary Cookies\n\nAlways Active\n\nThese cookies are necessary for the website to function and cannot be switched off in our systems. They are usually only set in response to actions made by you which amount to a request for services, such as setting your privacy preferences, logging in or filling in forms. You can set your browser to block or alert you about these cookies, but some parts of the site will not then work. These cookies do not store any personally identifiable information.\n\n#### Functional Cookies\n\nFunctional Cookies\n\nThese cookies enable the website to provide enhanced functionality and personalization. They may be set by us or by third party providers whose services we have added to our pages. If you do not allow these cookies then some or all of these services may not function properly.\n\n#### Performance Cookies\n\nPerformance Cookies\n\nThese cookies allow us to count visits and traffic sources so we can measure and improve the performance of our site. They help us to know which pages are the most and least popular and see how visitors move around the site. All information these cookies collect is aggregated and therefore anonymous. If you do not allow these cookies we will not know when you have visited our site, and will not be able to monitor its performance.\n\n#### Targeting Cookies\n\nTargeting Cookies\n\nThese cookies may be set through our site by our advertising partners. They may be used by those companies to build a profile of your interests and show you relevant adverts on other sites. They do not store directly personal information, but are based on uniquely identifying your browser and internet device. If you do not allow these cookies, you will experience less targeted advertising.\n\nBack Button\n\n### Cookie List\n\nSearch Icon\n\nFilter Icon\n\nClear\n\ncheckbox label label\n\nApply Cancel\n\nConsent Leg.Interest\n\ncheckbox label label\n\ncheckbox label label\n\ncheckbox label label\n\nOnly Essential Cookies Confirm My Choices\n\n[![Powered by Onetrust](https://cdn.cookielaw.org/logos/static/powered_by_logo.svg)](https://www.onetrust.com/products/cookie-consent/)\n"
        }
      ]
    }
  ]
}